Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH · 2025
Longitudinal Evaluation of Lower Urinary Tract Symptoms up to Six Months after COVID-19 Infection in a Jordanian Cohort.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sawaqed Fadi, Talahmeh Ghassan, Tarawneh Amjad, Sawaqed Seri, Kufoof Tamara, Al-Tamimi Malak, Alahmad Israa, Abu-Jeyyab Mohammad
Аннотация
BACKGROUND: Aortic Lower Urinary Tract Symptoms (LUTS) refer to a range of urinary symptoms affecting both men and women. These symptoms include increased frequency of urination, urgency, weak urine flow, incomplete emptying of the bladder, and nocturia.
OBJECTIVE: LUTS encompass various urinary issues, with emerging evidence suggesting a potential connection to COVID-19. This study aimed to evaluate the occurrence and long-term effects of COVID-19 on LUTS and IPSS across different infection severities.
METHODS: The prospective observational study enrolled 85 COVID-19 patients. IPSS was used to assess LUTS before, during, and 3 and 6 months after infection. Data collection included demographics and clinical characteristics, with follow-up assessments of all participants, highlighting significant differences between severity groups through statistical analysis.
RESULTS: The highest IPSS values occurred during the acute phase of infection in all groups. Patients with severe or critical COVID-19 exhibited the highest IPSS, while asymptomatic or mild cases had the lowest scores. IPSS scores showed a significant association across all phases in patients with a history of urological disorders compared to those without. Age was positively correlated with IPSS before and during infection. Long-term bladder dysfunction associated with COVID-19 may cause persistent LUTS in patients with mild cases.
CONCLUSION: A significant association exists between COVID-19 and LUTS, indicating that LUTS should be considered in COVID-19 cases. Monitoring LUTS is recommended throughout COVID-19 and during recovery. However, pre-infection LUTS were assessed retrospectively through recall of IPSS scores, which may be subject to recall bias and could affect the accuracy of pre- and post-infection comparisons. This study is among the first to provide a 6-month longitudinal follow-up with predictors such as age and urological history. Limitations include the lack of control for confounding factors and potential recall bias, though the within-subject repeated design enhances the strength of the results.
OBJECTIVE: LUTS encompass various urinary issues, with emerging evidence suggesting a potential connection to COVID-19. This study aimed to evaluate the occurrence and long-term effects of COVID-19 on LUTS and IPSS across different infection severities.
METHODS: The prospective observational study enrolled 85 COVID-19 patients. IPSS was used to assess LUTS before, during, and 3 and 6 months after infection. Data collection included demographics and clinical characteristics, with follow-up assessments of all participants, highlighting significant differences between severity groups through statistical analysis.
RESULTS: The highest IPSS values occurred during the acute phase of infection in all groups. Patients with severe or critical COVID-19 exhibited the highest IPSS, while asymptomatic or mild cases had the lowest scores. IPSS scores showed a significant association across all phases in patients with a history of urological disorders compared to those without. Age was positively correlated with IPSS before and during infection. Long-term bladder dysfunction associated with COVID-19 may cause persistent LUTS in patients with mild cases.
CONCLUSION: A significant association exists between COVID-19 and LUTS, indicating that LUTS should be considered in COVID-19 cases. Monitoring LUTS is recommended throughout COVID-19 and during recovery. However, pre-infection LUTS were assessed retrospectively through recall of IPSS scores, which may be subject to recall bias and could affect the accuracy of pre- and post-infection comparisons. This study is among the first to provide a 6-month longitudinal follow-up with predictors such as age and urological history. Limitations include the lack of control for confounding factors and potential recall bias, though the within-subject repeated design enhances the strength of the results.